Evidence map›Paper›PMID 40453415›Full record

ArticleMDM policy & practice

Exploring the Role of Patient Preferences in Hepatocellular Carcinoma Treatment Decisions: A Qualitative Study.

Andrew M Moon, Daniel Richardson, Gabriel V Lupu, Donna M Evon, Hanna K Sanoff, Jessica Carda-Auten, Randall Teal, Myra Waheed, Ethan Basch, David M Mauro and 16 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in MDM policy & practice. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

26 authors.

Andrew M MoonDivision of Gastroenterology and Hepatology, University of North Carolina at Chapel Hill School of Medicine, Chapel Hill, NC, USA.ORCID https://orcid.org/0000-0001-7163-2062
Daniel RichardsonLineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill, NC, USA.
Gabriel V LupuDivision of Gastroenterology and Hepatology, University of North Carolina at Chapel Hill School of Medicine, Chapel Hill, NC, USA.ORCID https://orcid.org/0009-0004-3135-2161
Donna M EvonDivision of Gastroenterology and Hepatology, University of North Carolina at Chapel Hill School of Medicine, Chapel Hill, NC, USA.
Hanna K SanoffLineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill, NC, USA.
Jessica Carda-AutenLineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill, NC, USA.
Randall TealLineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill, NC, USA.
Myra WaheedLineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill, NC, USA.
Ethan BaschLineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill, NC, USA.ORCID https://orcid.org/0000-0003-3813-9318
David M MauroDivision of Interventional Radiology, University of North Carolina at Chapel Hill School of Medicine, Chapel Hill, NC, USA.
Ted K YanagiharaLineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill, NC, USA.
David A GerberDepartment of Surgery, University of Cincinnati, Cincinnati, OH, USA.
Neil D ShahDivision of Gastroenterology and Hepatology, University of North Carolina at Chapel Hill School of Medicine, Chapel Hill, NC, USA.
Oren K FixDivision of Gastroenterology and Hepatology, University of North Carolina at Chapel Hill School of Medicine, Chapel Hill, NC, USA.
Hersh ShroffDivision of Gastroenterology and Hepatology, University of North Carolina at Chapel Hill School of Medicine, Chapel Hill, NC, USA.
Tammy TriglianosDivision of Oncology, Department of Medicine, University of North Carolina at Chapel Hill School of Medicine, Chapel Hill, NC, USA.
Jonathan D SorahLineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill, NC, USA.
Jingquan JiaLineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill, NC, USA.
Ashwin SomasundaramLineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill, NC, USA.
Lynne I WagnerLineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill, NC, USA.
Michael D KappelmanDepartment of Pediatrics, Division of Pediatric Gastroenterology, University of North Carolina, Chapel Hill, NC, USA.
Matthew SchoolerDivision of Abdominal Transplant, University of North Carolina, Chapel Hill, NC, USA.
Julia R PhillipsCenter for Esophageal Diseases & Swallowing (CEDAS), University of North Carolina, Chapel Hill, NC, USA.
Hiwot A EkubanCenter for Esophageal Diseases & Swallowing (CEDAS), University of North Carolina, Chapel Hill, NC, USA.
Ariel E SanderfordCenter for Esophageal Diseases & Swallowing (CEDAS), University of North Carolina, Chapel Hill, NC, USA.
A Sidney BarrittDivision of Gastroenterology and Hepatology, University of North Carolina at Chapel Hill School of Medicine, Chapel Hill, NC, USA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Highlights: Hepatocellular carcinoma (HCC) treatment decisions are often complex and may become increasingly so as new treatment options emerge.Improved understanding of tradeoffs and patient preferences in treatment decisions will enhance patient-provider discussions, facilitate patient-centered trials to develop new treatments, and inform HCC treatment guidelines.This qualitative study of patients and providers provided information on the values considered in HCC treatment decisions and the importance of considering the tradeoffs of efficacy, toxicity, and inconvenience/costs.These insights can be used to develop preference elicitation tools, perform large-scale preference elicitation surveys, and systematically assess and incorporate patient preferences into treatment decisions.

Indexed as

choiceliver cancervalues

Identifiers

PMID40453415
PMCPMC12123149

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.